Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10817 - 10824 of 11440 results
ML Strategies Posts Weekly Health Care Reform Update on June 11, 2012
June 12, 2012| Blog| Viewpoint
OCR Shares Preliminary HITECH Audit Results; What Regulated Entities Can Expect Next
June 11, 2012| Blog| Viewpoint
Is It Proper To Say You Google On GOOGLE®?
June 9, 2012| Blog| Viewpoint
Weekend Reading
June 8, 2012| Blog| Viewpoint
LinkedIn Passwords Hacked - UPDATE
June 6, 2012| Blog| Viewpoint
USCIS ELIS: New Online Processing of Immigration Applications
June 5, 2012| Blog| Viewpoint
Updated Mintz Matrix
June 4, 2012| Blog| Viewpoint
OIG Advisory Opinion 12-06 Disapproves of Proposed Arrangements Between ASCs and Anesthesia Services Providers
June 3, 2012| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.